Chevron Corp. (NYSE:CVX): Oil traded near the highest close in about three weeks in New York amid speculation the U.S. intends to add to measures to revive its economy, which counters concern that Europe’s bailout plan will falter. The Fed starts a two-day meeting tomorrow where it could announce stimulus measures, according to Bloomberg. The shares closed at $114.18, up $0.22 or 0.19% on the day. They have traded in a 52-week range of $86.68 to $114.54.
R.G. Barry Corp. (NASDAQ:DFZ) reports a Q4 EPS of 4c, one estimate (1c). The shares closed at $14.44, down $0.12 or 0.82% on the day. They have traded in a 52-week range of $9.27 to $14.74.
Five Star Quality (AMEX:FVE) has received $30.5 million in sale proceeds from Omnicare (NYSE:OCR). Additionally, Five Star sold to Omnicare, or retained, particular items of net working capital invested in its pharmacy business which, based on June 30, 2012 amounts, is about $8.2 million. Currently, Five Star expects to receive a total of $38.7 million in net cash receipts resulting from the sale and to record a capital gain of nearly $23.3 million. The shares closed at $4.96, up $0 or 0% on the day. They have traded in a 52-week range of $2.15 to $5.06.
Gannett Co. (NYSE:GCI): CareerBuilder is making a big strategic move that will change the game for online recruitment. The company announced its acquisition of Economic Modeling Specialists International, which is an economic software firm specializing in employment data and labor market analysis. Joining forces, CareerBuilder and EMSI will provide clients with a truly unique perspective regarding current and future employment trends, skills development, and recruitment strategies. For the past few years, CareerBuilder has been investing in a Workforce Analytics platform tracking hiring and job search trends to assist companies in the identification of the best markets for finding in-demand talent. Owned by Gannett, Tribune Company and The McClatchy Company (NYSE:MNI), CareerBuilder and its subsidiaries are operating in the U.S., Europe, South America, Canada and Asia. The shares closed at $17.00, up $0.7 or 4.29% on the day. They have traded in a 52-week range of $8.28 to $16.33.
General Electric (NYSE:GE): GE Healthcare announced pooled results from phase III brain autopsy and biopsy studies on the investigational PET amyloid imaging agent, flutemetamol, indicated a strong concordance between flutemetamol images and Alzheimer’s disease-associated beta amyloid brain pathology. Flutemetamol is a PET imaging agent that is being developed by GE Healthcare to detect beta amyloid deposits in the brain. The data from the phase III studies further confirm the possible application of flutemetamol as an imaging agent to detect beta amyloid plaques. The shares closed at $21.59, up $0.11 or 0.51% on the day. They have traded in a 52-week range of $14.02 to $21.65.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>